Aripiprazole Tablet
Product Images NDC 71205-392

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 71205-392). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: The Effects Of Other Drugs On Aripiprazole Pharmacokinetics (Aripiprazole Fig1)

A figure titled 'The effects of other drugs on aripiprazole pharmacokinetics' showing a chart of aripiprazole fold change with 90% confidence intervals. It lists drugs such as ketoconazole, quinidine, carbamazepine, famotidine, valproate, and lorazepam on the y-axis, with fold change relative to a reference (without interacting drug) on the x-axis. The chart shows changes in AUC and Cmax for each listed interacting drug.*

FDA Label Image

Figure 2: The Effects Of Other Drugs On Dehydro-aripiprazole Pharmacokinetics (Aripiprazole Fig2)

A chart titled 'The effects of other drugs on dehydro-aripiprazole pharmacokinetics' showing fold changes and 90% confidence intervals for dehydro-aripiprazole AUC and Cmax levels when co-administered with various drugs including CYP3A4 inhibitor ketoconazole, CYP2D6 inhibitor quinidine, CYP3A4 inducer carbamazepine, gastric acid blocker famotidine, and others like valproate and lorazepam. The x-axis represents change relative to reference without interacting drug, ranging from 0 to 3.*

FDA Label Image

Figure3: The Effects Of Aripiprazole On Pharmacokinetics Of Other Drugs (Aripiprazole Fig3)

A pharmacokinetic graph titled 'The effects of aripiprazole on pharmacokinetics of other drugs' showing fold change and 90% confidence intervals for various drugs including dextromethorphan, warfarin (S- and R-), omeprazole, lamotrigine, valproate, lorazepam, venlafaxine, and O-desmethylvenlafaxine. The x-axis represents change relative to reference without interacting drug, ranging from 0.5 to 3.0, and the y-axis lists the drugs and pharmacokinetic parameters (AUC, Cmax, INR, DM/DRP).*

FDA Label Image

Figure4: Effects Of Intrinsic Factors On Aripiprazole Pharmacokinetics (Aripiprazole Fig4)

A chart depicting Aripiprazole fold change with 90% confidence intervals across special populations. It compares pharmacokinetic measures (AUC and Cmax) showing variations in poor versus extensive metabolizers of CYP2D6, gender, age groups, hepatic impairment levels (mild, moderate, severe), and severe renal impairment relative to reference values on a scale from 0.5 to 3.0 fold change.*

FDA Label Image

Figure 5: Effects Of Intrinsic Factors On Dehydro-aripiprazole Pharmacokinetics (Aripiprazole Fig5)

A pharmacokinetic chart titled 'Effects of intrinsic factors on dehydro-aripiprazole pharmacokinetics' showing fold change and 90% confidence intervals for variables including CYP2D6 metabolizer status, gender, age, hepatic impairment severity, and severe renal impairment. The x-axis represents change relative to reference, ranging from 0.5 to 3.0, and the y-axis measures pharmacokinetic parameters AUC and Cmax.*

FDA Label Image

Figure 6: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Relapse (schizophrenia Study 5) (Aripiprazole Fig6)

Kaplan-Meier estimation graph depicting the cumulative proportion of patients with relapse in Schizophrenia Study 5, comparing Aripiprazole and placebo groups over 182 days from randomization. The y-axis shows proportion with relapse, and the x-axis shows days from randomization, with number of subjects at risk listed below. Solid line represents Aripiprazole, dashed line represents placebo.*

FDA Label Image

71205-392-30 (Aripiprazole Fig9)

Label for Aripiprazole 5 mg tablets by Proficient Rx LP. The label indicates 30 tablets per bottle, each containing 5 mg of Aripiprazole USP. Tablets are described as blue, modified rectangular, uncoated with '62' and 'H' debossed. Includes storage instructions and manufacturing info by Aurobindo Pharma Limited, India.*

FDA Label Image

Aripiprazole Structure (Aripiprazole Str)

Chemical structure of Aripiprazole shown as a molecular diagram with chlorine-substituted aromatic rings, piperazine, and a quinolinone moiety connected by an ether-linked chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.